These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3427825)

  • 1. Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states.
    Korver K; Boeschoten EW; Krediet RT; van Steenis G; Schellekens PT
    Clin Exp Immunol; 1987 Nov; 70(2):328-35. PubMed ID: 3427825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation.
    Gore ER; Gower J; Kurali E; Sui JL; Bynum J; Ennulat D; Herzyk DJ
    Toxicology; 2004 Apr; 197(1):23-35. PubMed ID: 15003331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant effects of freely ingested cholera toxin on systemic antibody and DTH responses to protein antigen.
    Kusnecov AW; Cohen N; Moynihan J
    Reg Immunol; 1992; 4(3):153-61. PubMed ID: 1303098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
    Chapman PB; Morrissey DM; Panageas KS; Hamilton WB; Zhan C; Destro AN; Williams L; Israel RJ; Livingston PO
    Clin Cancer Res; 2000 Mar; 6(3):874-9. PubMed ID: 10741710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
    Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
    Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
    Slovin SF; Ragupathi G; Musselli C; Fernandez C; Diani M; Verbel D; Danishefsky S; Livingston P; Scher HI
    Cancer Immunol Immunother; 2005 Jul; 54(7):694-702. PubMed ID: 15726361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of C3bgp on the antibody response to hemocyanin in outbred rabbits and the F1 generation of breeding with siblings.
    Stanilova SA; Miteva LD; Tanchev SG
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):15-21. PubMed ID: 15910989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men.
    Smith TP; Kennedy SL; Fleshner M
    J Appl Physiol (1985); 2004 Aug; 97(2):491-8. PubMed ID: 15247195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin.
    Chapman PB; Morrisey D; Panageas KS; Williams L; Lewis JJ; Israel RJ; Hamilton WB; Livingston PO
    Clin Cancer Res; 2000 Dec; 6(12):4658-62. PubMed ID: 11156217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of systemic antigen-specific immune responses by oral antigen in humans.
    Kapp K; Maul J; Hostmann A; Mundt P; Preiss JC; Wenzel A; Thiel A; Zeitz M; Ullrich R; Duchmann R
    Eur J Immunol; 2010 Nov; 40(11):3128-37. PubMed ID: 20957752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats.
    Kawai R; Ito S; Aida T; Hattori H; Kimura T; Furukawa T; Mori K; Sanbuissho A; Kawada T
    J Immunotoxicol; 2013; 10(1):40-8. PubMed ID: 22953734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV).
    Uytdehaag FG; Osterhaus AD; Loggen HG; Bakker RH; van Asten JA; Kreeftenberg JG; van der Marel P; van Steenis B
    J Immunol; 1983 Sep; 131(3):1234-9. PubMed ID: 6193180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.
    Jurincic-Winkler CD; von der Kammer H; Beuth J; Scheit KH; Klippel KF
    Anticancer Res; 1996; 16(4A):2105-10. PubMed ID: 8712751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impairment of local intestinal immune response to keyhole limpet haemocyanin in the absence of Peyer's patches.
    Hamilton SR; Keren DF; Yardley JH; Brown G
    Immunology; 1981 Mar; 42(3):431-5. PubMed ID: 7203530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
    Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in dog. 3. Antibody formation in dogs and rabbits to human serum proteins and keyhole limpet haemocyanin.
    Mates A; Hinton NA
    Microbios; 1976; 17(70):175-87. PubMed ID: 74005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte proliferative response to rabies virus antigen.
    Melino G; Concato C; Menichella D; Vescia N; Mastroeni I; Pestalozza S; Buonavoglia C; Caliò R
    Microbiologica; 1989 Jul; 12(3):215-23. PubMed ID: 2779457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.